Skip to Content

LK16-03

Main Content

Allogeneic transplantation to treat therapy related acute myeloid leukemia and myelodysplastic syndromes.

Study #: LK16-03

Study Status: Published

Presentation(s)

2019, ASH (Poster)

Allogeneic transplantation to treat therapy-related myelodysplastic syndrome and acute myelogenous leukemia in adults.

Citation

Metheny L, Callander NS, Hall AC, Zhang M-J, Bo-Subait K, Wang H-L, Agrawal V, Al-Homsi AS, Assal A, Bacher U, Beitinjaneh A, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Cairo M, Cerny J, DeFilipp Z, Perez MAD, Freytes CO, Ganguly S, Grunwald MR, Hashmi S, Hildebrandt GC, Inamoto Y, Kanakry CG, Kharfan-Dabaja MA, Lazarus HM, Lee JW, Nathan S, Nishihori T, Olsson RF, Ringdén O, Rizzieri D, Savani BN, Savoie ML, Seo S, van der Poel M, Verdonck LF, Wagner JL, Yared JA, Hourigan CS, Kebriaei P, Litzow M, Sandmaier BM, Saber W, Weisdorf D, de Lima M.

Transplantation and Cellular Therapy. 2021, Nov 01: 27(11): 27(11):923.e1-923.e12. doi: 10.1016/j.jtct.2021.08.010. Epub 2021, Aug 21. PMCID:PMC9064046.

PubMed

PMID: 34428556

Abstract